trovafloxacin has been researched along with Pneumonia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boada, C; Boada, JN; Fernández, E; García, M; García-Sáiz, M; Gómez, E | 1 |
| Aguilar, L; Blanquer, R; Caminero, J; Custardoy, J; Dal-Ré, R; Durán, J; García-Méndez, E; García-Rey, C; Gil-Aguado, A; Grau, I; Ibáñez, D; Llorca, E; Martínez, J; Mensa, J; Molinos, L; Moreno, S; Palacios, R; Pallarés, R; Santos, J; Siquier, B; Vidal, J | 1 |
| Azoulay-Dupuis, E; Bauchet, J; Bédos, JP; Carbon, C; Muffat-Joly, M; Rieux, V | 1 |
| Cunha, BA; Goel, K; Menzies, D | 1 |
| Fleurinck, C; Germonpré, PR; Pauwels, RA; Peleman, RA; Rosseel, MT; Van De Velde, V | 1 |
| Hammerschlag, MR | 1 |
| Acampora, MD; Busman, TA; Notario, GF; Sokol, WN; Sullivan, JG | 1 |
2 trial(s) available for trovafloxacin and Pneumonia
| Article | Year |
|---|---|
Clinical characteristics and response to newer quinolones in Legionella pneumonia: a report of 28 cases.
Topics: Community-Acquired Infections; Drug Resistance, Microbial; Fluoroquinolones; Gemifloxacin; Humans; Immunoglobulin G; Legionella; Legionellosis; Naphthyridines; Pneumonia; Treatment Outcome | 2003 |
A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Community-Acquired Infections; Delayed-Action Preparations; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Naphthyridines; Pneumonia; Prospective Studies; Radiography; Treatment Outcome | 2002 |
5 other study(ies) available for trovafloxacin and Pneumonia
| Article | Year |
|---|---|
Net efficacy adjusted for risk (NEAR): a simple procedure for measuring risk:benefit balance.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cardiovascular Diseases; Drug-Related Side Effects and Adverse Reactions; Fluoroquinolones; Gemifloxacin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Theoretical; Naphthyridines; Pneumonia; Preventive Medicine; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome | 2008 |
Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Drug Resistance, Multiple; Female; Fluoroquinolones; Half-Life; Leukopenia; Lung; Mice; Naphthyridines; Penicillins; Pneumococcal Infections; Pneumonia; Streptococcus pneumoniae | 1998 |
Elevated international normalized ratio associated with trovafloxacin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Appendicitis; Blood Coagulation; Cellulitis; Female; Fluoroquinolones; Hemorrhage; Humans; International Normalized Ratio; Kidney Calculi; Male; Middle Aged; Naphthyridines; Pneumonia | 1999 |
Trovafloxacin concentrations in airway fluids of patients with severe community-acquired pneumonia.
Topics: Adult; Aged; Anti-Infective Agents; Bronchi; Bronchoalveolar Lavage Fluid; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Naphthyridines; Pneumonia; Sputum | 2000 |
Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin.
Topics: Anti-Infective Agents; Community-Acquired Infections; Double-Blind Method; Fluoroquinolones; Gemifloxacin; Humans; Naphthyridines; Pneumonia; Randomized Controlled Trials as Topic | 2001 |